Last reviewed · How we verify

NCT05673551

VR-PAT During Home Burn Dressings - Multisite

ENROLLING BY INVITATION NA Last updated 19 June 2025
What this trial tests

NA trial testing VR-PAT in Burns in 220 participants. Enrolling by invitation.

Timeline
16 January 2023
Primary endpoint
1 December 2027
1 December 2027

Quick facts

Lead sponsorNationwide Children's Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment220
Start date16 January 2023
Primary completion1 December 2027
Estimated completion1 December 2027
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Nationwide Children's Hospital

Who can join

Adults 6 to 17, any sex, with Burns or Acute Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the effectiveness of smartphone Virtual Reality Pain Alleviation Therapy (VR-PAT) as a pain distraction tool during repeated at-home burn dressing changes among 100 children (age 6-17 years) with a burn injury in comparison to 100 children with a burn injury who do not use the VR-PAT.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Smartphone virtual reality for pain management during pediatric burn care transition: study protocol for a randomized controlled trial.
    Armstrong M, Price A, Coffey R, Noffsinger D, et al · · 2025 · cited 1× · PMID 40361220 · DOI 10.1186/s13063-025-08860-4

Verify or expand the search:

Other trials of VR-PAT

Trials testing the same drug.

Other recruiting trials for Burns

Currently open trials in the same condition.

Other Nationwide Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05673551.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing